Rocio Pillado
Partner @ Adara Ventures
Madrid, Spain
Rocio Pillado is a seed investor at Adara Ventures in Madrid focused on Artificial Intelligence and Health Care. Rocío joined Adara in 2013 after finishing her MBA at The University of Chicago Booth School of Business. Before Adara, Rocío worked at Société Générale Corporate & Investment Banking (SGCIB) within the Trading & Sales department, in the New York and Hong Kong offices. She worked as a project leader and software engineer, designing andbuilding trading software. Previously, Rocío worked in France in the security field, both as a consultant and as an engineer. She worked in projects related to system security and monitoring, secure software for smart cards, and database availability. Rocío is also the co-founder of Club-MBA.com, the leading website in the Spanish language about MBA and other graduate programs.Rocío holds an engineering degree in Computer Science from the Universidad Politécnica de Madrid and another from the École Nationale Supérieure d'Informatique et de Mathématiques Appliquées (ENSIMAG). She also holds an MSc in Cryptology, Security and Information Coding from the Institut Fourier.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Rocio Pillado invests in
Stages Rocio Pillado invests in
Countries Rocio Pillado invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 3 (43%)
- Health Care 2 (29%)
- Health Diagnostics 2 (29%)
- EdTech 1 (14%)
- Medical 1 (14%)
Stage
- Seed 3 (43%)
- Series A 3 (43%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TuringDream redefines education. Deeply personal, broadly available, and substantially cheaper. | $7.1M / Seed / Jul 02, 2025 | ||
| indigitall the mission to help its Customers in their digital transformation and to improve user experience through value added solutions in mobility. Ever since, indigitall has developed a unique global solution that enables its Customers to establish enriched, personalised and segmented communication with its users through their mobileapplications and/or websites. Their vision is to be one of the leading global platforms in automated marketing. The key to their differentiation is the continuous commitment to their solution’s INNOVATION and FLEXIBILITY and to their Customers’ specific needs. indigitall already has a presence in Spain, Italy, Colombia and Mexico, with the short-term goal of establishing itself in other countries. | $6.4M / Series A / Apr 23, 2024 | ||
| visual+cognitive enhancement | $4.3M / Series A / Feb 19, 2024 | ||
| IOMED Medical Solutions develops a medical record management software aimed at structuring clinical data and the generation of artificial intelligence tools.A technology, based on Natural Language Processing, that allows structure clinical text, obtaining reusable data for the development of medical predictive models. It saves costs andeffectively assigns resources by extracting insights from a hospital's clinical notes and data management. The company's software uses artificial intelligence and cognitive computing to organize and visualize medical records information and offers data structuring, integration, and interoperability, providing clinicians with efficiency, information, and savings needed to make more efficient decisions.Alvaro Abella, Gabriel de Maeztu, and Javier Oca founded the company in Barcelona, Catalonia in 2016. | $11M / Series A / Sep 12, 2023 | ||
| IOMED Medical Solutions develops a medical record management software aimed at structuring clinical data and the generation of artificial intelligence tools.A technology, based on Natural Language Processing, that allows structure clinical text, obtaining reusable data for the development of medical predictive models. It saves costs andeffectively assigns resources by extracting insights from a hospital's clinical notes and data management. The company's software uses artificial intelligence and cognitive computing to organize and visualize medical records information and offers data structuring, integration, and interoperability, providing clinicians with efficiency, information, and savings needed to make more efficient decisions.Alvaro Abella, Gabriel de Maeztu, and Javier Oca founded the company in Barcelona, Catalonia in 2016. | $2.2M / Sep 03, 2020 | ||
| IOMED Medical Solutions develops a medical record management software aimed at structuring clinical data and the generation of artificial intelligence tools.A technology, based on Natural Language Processing, that allows structure clinical text, obtaining reusable data for the development of medical predictive models. It saves costs andeffectively assigns resources by extracting insights from a hospital's clinical notes and data management. The company's software uses artificial intelligence and cognitive computing to organize and visualize medical records information and offers data structuring, integration, and interoperability, providing clinicians with efficiency, information, and savings needed to make more efficient decisions.Alvaro Abella, Gabriel de Maeztu, and Javier Oca founded the company in Barcelona, Catalonia in 2016. | $2.4M / Seed / Sep 03, 2020 | ||
| Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy ofnovel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human. | $9.2M / Seed / Jul 21, 2020 |
Co-Investors
About Adara Ventures
Adara Ventures focuses on sectors such as cybersecurity, applied artificial intelligence, data infrastructure, and energy transition to support the modernization of enterprise capabilities. Its investment strategy includes backing founders who develop specialized hardware components, digital health solutions, and scalable software for industrial automation. The firm provides both seed and Series A capital, assisting startups with product validation and international go-to-market execution. By managing a portfolio across multiple funds, the entity facilitates the growth of businesses that address complex technical challenges in the digital economy.
Adara Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Monica Navas
Head of Investor Relations
|
|||
Nicolas Goulet
Managing Partner
|
|||
|
Rocio Pillado
Partner
|
|||
Ross Strachan
Partner
|
|||
Alberto Arreaza
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Rocio Pillado invest in?
Rocio Pillado invests primarily in Artificial Intelligence, Health Care and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Rocio Pillado?
Public channels for Rocio Pillado include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Rocio Pillado last invest?
The most recent investment recorded for Rocio Pillado closed in Jul 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
